Biotech Companies

1115 companies | Drug discovery and development companies

#	COMPANY	THERAPEUTIC AREAS	STAGE
1.	180 Collagen (NZ) Limited Te Awamutu, New Zealand		Commercial	VIEW
2.	1ST Biotherapeutics, Inc. Yongin, South Korea	Rare Diseases	Phase 1	VIEW
3.	3SBio Inc. Shenyang, China	Oncology Hematology Immunology	Phase 3	VIEW
4.	4 Animals AlsterScience GmbH Hamburg, Germany	Immunology Oncology Infectious Disease	Preclinical	VIEW
5.	4D Pharma plc Leeds, United Kingdom	Oncology Immunology Gastroenterology	Preclinical to Phase II (at time of administration)	VIEW
6.	AC Immune SA Lausanne, Switzerland		Phase 2	VIEW
7.	ACI Limited Dhaka, Bangladesh		Commercial	VIEW
8.	ADARx Pharmaceuticals San Diego, USA	Neuroscience Immunology Oncology	Phase 3	VIEW
9.	ADMA Biologics, Inc. Ramsey, New Jersey, United States		Commercial + Preclinical	VIEW
10.	AGS Therapeutics Paris, France	Ophthalmology Immunology Infectious Disease+2	Preclinical	VIEW
11.	AMR Action Fund Boston, United States	Infectious Disease	Phase 2/3 focus	VIEW
12.	ANLIS Malbrán Buenos Aires, Argentina	Infectious Disease	Discovery	VIEW
13.	ANSTO (Australian Nuclear Science and Technology Organisation) Sydney, Australia	Oncology Cardiovascular Neuroscience	Commercial	VIEW
14.	ARCS Australia North Sydney, Australia		-	VIEW
15.	ASKA Pharmaceutical Co., Ltd. Tokyo, Japan	Gastroenterology	Commercial	VIEW
16.	Aardvark Therapeutics San Diego, USA	Rare Diseases Metabolic	Phase 3	VIEW
17.	AbCellera Vancouver, Canada	Metabolic Immunology Oncology	Phase 2	VIEW
18.	Abbisko Therapeutics Shanghai, China	Oncology	Phase 3	VIEW
19.	Abcuro, Inc. Newton, Massachusetts, USA	Immunology Oncology Rare Diseases	Phase 2/3	VIEW
20.	Abdera Therapeutics South San Francisco, USA / Vancouver, Canada	Oncology	Phase 1	VIEW
21.	Abeona Therapeutics Inc. Cleveland, Ohio, USA	Rare Diseases Ophthalmology Dermatology	Commercial	VIEW
22.	Abiogen Pharma S.p.A. Pisa, Italy	Respiratory Metabolic Dermatology+1	Commercial	VIEW
23.	Abivax Paris, France	Immunology Gastroenterology	Phase 3	VIEW
24.	Acadia Pharmaceuticals Inc. San Diego, USA	Neuroscience Rare Diseases	Commercial	VIEW
25.	Acelot South San Francisco, California, USA	Metabolic Oncology	Preclinical	VIEW
26.	Acepodia Alameda, USA / Taipei, Taiwan	Oncology Immunology	Phase 1	VIEW
27.	Acerand Therapeutics Carmel, USA / Shanghai, China	Oncology Immunology	Phase 1/2	VIEW
28.	Acrux Melbourne, Australia	Dermatology Metabolic	Commercial	VIEW
29.	Actigen Company Limited Samut Sakhon, Thailand		Discovery	VIEW
30.	Actinogen Medical Sydney, Australia		Phase 2/3	VIEW
31.	AcuraStem Monrovia, California, USA		Preclinical	VIEW
32.	Adgyll Lifesciences		-	VIEW
33.	Adium (Adium Paraguay / Fapasa) Asunción, Paraguay	Cardiovascular Metabolic Neuroscience+2	Commercial	VIEW
34.	AdvantiGen Biosciences Madison, WI, United States	Oncology Immunology	Discovery	VIEW
35.	Advanz Pharma London, United Kingdom	Gastroenterology Metabolic Oncology+2	Commercial\|Phase 2\|Phase 3	VIEW
36.	Aegros Macquarie Park, Australia	Infectious Disease Immunology	Clinical	VIEW
37.	Aerogen Pharma San Mateo, USA / Galway, Ireland	Respiratory	Phase 3	VIEW
38.	Affitech Copenhagen, Denmark (with R&D in Oslo, Norway and San Francisco, USA)	Oncology Immunology Infectious Disease	Clinical	VIEW
39.	AgeneBio Baltimore, MD, USA	Neuroscience	Phase 2	VIEW
40.	Agios Pharmaceuticals Cambridge, USA	Rare Diseases Hematology Metabolic	Commercial	VIEW
41.	Agomab Therapeutics Antwerp, Belgium	Gastroenterology Rare Diseases	Phase 2	VIEW
42.	AiCuris Anti-infective Cures AG Wuppertal, Germany	Infectious Disease	Phase 3	VIEW
43.	Aitia Somerville, Massachusetts, USA	Oncology Immunology	Discovery	VIEW
44.	Ajou University Suwon, South Korea	Oncology Immunology Neuroscience+2	Phase 3	VIEW
45.	Akebia Therapeutics Cambridge, USA	Rare Diseases	Commercial	VIEW
46.	Akeso, Inc. Guangdong, China	Oncology Immunology	Commercial	VIEW
47.	Akribes Biomedical Vienna, Austria	Dermatology	Preclinical	VIEW
48.	Al-Razi Pharma Industries Dammam, Saudi Arabia		Commercial	VIEW
49.	Alchemab Therapeutics Cambridge, United Kingdom	Oncology Immunology	Phase 1	VIEW
50.	Alembic Pharmaceuticals Limited Vadodara, India	Cardiovascular Dermatology Oncology+3	Commercial	VIEW
51.	AlgiPharma AS Sandvika, Norway	Respiratory Infectious Disease	Phase 2	VIEW
52.	Alkermes plc Dublin, Ireland	Neuroscience	Commercial	VIEW
53.	Alkeus Pharmaceuticals Cambridge, USA	Ophthalmology Rare Diseases	Phase 3	VIEW
54.	Allergy Therapeutics Worthing, United Kingdom		Phase 3 and Phase 1/2	VIEW
55.	Allygen Biosciences Shanghai, China	Oncology Immunology	Preclinical	VIEW
56.	Alnylam Pharmaceuticals Cambridge, USA	Infectious Disease	Commercial	VIEW
57.	AlphaGen Therapeutics Shanghai, China	Oncology	Preclinical	VIEW
58.	AltruBio, Inc. San Francisco, USA	Immunology	Phase 2	VIEW
59.	Alumis Inc. South San Francisco, USA	Immunology Dermatology Neuroscience+1	Phase 3	VIEW
60.	Alvotech Luxembourg, Luxembourg	Immunology Ophthalmology Oncology+1	Commercial	VIEW
61.	Amanys Pharma Aïn El Aouda, Morocco	Hematology	Commercial	VIEW
62.	Amarin Corporation plc Dublin, Ireland	Cardiovascular	Commercial	VIEW
63.	Amicus Therapeutics Princeton, New Jersey, USA	Rare Diseases Metabolic	Commercial	VIEW
64.	Ampersand Biomedicines Boston, MA, USA	Metabolic	Preclinical	VIEW
65.	Amylyx Pharmaceuticals Cambridge, USA	Rare Diseases	Phase 3	VIEW
66.	Anavex Life Sciences Corp. New York, United States	Oncology	Phase 2\|Phase 3	VIEW
67.	Angal Biotechnologies Ltd. Suzhou, China	Oncology Infectious Disease	Preclinical	VIEW
68.	Angelini Pharma Rome, Italy	Neuroscience Infectious Disease	Phase 3	VIEW
69.	Anika Therapeutics, Inc. Bedford, Massachusetts, USA		Commercial	VIEW
70.	Anocca AB Södertälje, Sweden	Oncology Immunology Infectious Disease	Phase 1	VIEW
71.	Antaria Limited Perth, Australia		-	VIEW
72.	Anwita Biosciences, Inc. San Carlos, USA	Oncology	Phase 1	VIEW
73.	Anyea Therapeutics Co., Ltd. Shanghai, China	Neuroscience	Discovery	VIEW
74.	Apateya Bordeaux, France	Neuroscience	Preclinical	VIEW
75.	Apeiron Therapeutics (GT Apeiron LLC) Burlingame, USA / Shanghai, China	Oncology	Phase 1	VIEW
76.	Apellis Pharmaceuticals, Inc. Waltham, Massachusetts, USA	Ophthalmology Rare Diseases Immunology	Commercial	VIEW
77.	ApicHope Pharmaceutical Group Co., Ltd. Guangzhou, China	Metabolic Infectious Disease	Phase 3	VIEW
78.	Apogee Therapeutics, Inc. Waltham, USA	Dermatology Respiratory	Phase 2	VIEW
79.	Apotex Inc. Toronto, Canada	Cardiovascular Oncology Neuroscience+1	Commercial	VIEW
80.	Appili Therapeutics Inc. Halifax, Canada	Infectious Disease	Commercial	VIEW
81.	Aprogen Seongnam-si, South Korea	Oncology Immunology	Commercial	VIEW
82.	Apsen Farmacêutica São Paulo, Brazil	Neuroscience Gastroenterology	Phase 3	VIEW
83.	Aptose Biosciences Inc. Toronto, Canada	Oncology Hematology	Phase 2	VIEW
84.	Aquinas Companies, LLC (Fannin Innovation Studio) Houston, Texas, USA	Oncology Infectious Disease Cardiovascular+2	Phase 2	VIEW
85.	Araceli Biosciences Tigard, Oregon, United States		Seed	VIEW
86.	Aramis Biotechnologies Quebec City, Canada	Infectious Disease	Phase 1/2	VIEW
87.	Arcera Life Sciences Abu Dhabi, United Arab Emirates	Neuroscience Cardiovascular Gastroenterology+1	Commercial	VIEW
88.	Arcus Biosciences Hayward, United States	Oncology Immunology	Phase 3	VIEW
89.	Arcutis Biotherapeutics Westlake Village, California, United States	Dermatology	Commercial & Phase 1/2	VIEW
90.	Ardelyx Waltham, Massachusetts, USA	Gastroenterology	Commercial	VIEW
91.	Argo Biopharma Shanghai, China	Cardiovascular Metabolic Hematology+2	Phase 2	VIEW
92.	Aristo Pharmaceuticals Private Limited Mumbai, India	Gastroenterology Respiratory	Commercial	VIEW
93.	Aristopharma Ltd. Dhaka, Bangladesh	Oncology Cardiovascular	Commercial	VIEW
94.	Aristotle University of Thessaloniki - School of Pharmacy Thessaloniki, Greece	Oncology Neuroscience Immunology+1	Discovery	VIEW
95.	Ark Biosciences Shanghai, China	Respiratory Infectious Disease Neuroscience	Commercial	VIEW
96.	Arrivo BioVentures Morrisville, USA	Neuroscience Gastroenterology	Phase 2	VIEW
97.	Arrowhead Pharmaceuticals Pasadena, California, United States	Metabolic	Commercial \| Phase 3 \| Phase 2 \| Phase 1	VIEW
98.	Artica Therapeutics Leiden, Netherlands	Immunology	Preclinical	VIEW
99.	Artificial Axon Labs Cambridge, Massachusetts, USA	Neuroscience	Discovery	VIEW
100.	Arvinas, Inc. New Haven, Connecticut, United States	Oncology Neuroscience	Phase 1-3	VIEW
101.	AryoGen Pharmed Karaj, Iran	Oncology Immunology Hematology	Commercial	VIEW
102.	Ascentage Pharma Suzhou, China	Oncology	Commercial	VIEW
103.	Asclepii Cleveland, USA		Commercial	VIEW
104.	Asha Cellulose (I) Pvt. Ltd. Mumbai, India		-	VIEW
105.	Asia Euro Pharmaceutical Hanoi, Vietnam	Cardiovascular Respiratory Dermatology	Commercial	VIEW
106.	Asimetra Biotech Solutions Girona, Spain		-	VIEW
107.	AskGene Camarillo, California, United States	Oncology Immunology Ophthalmology	Phase 3	VIEW
108.	Asklepion Pharmaceuticals, LLC Baltimore, Maryland, USA		Phase 3	VIEW
109.	Asklepios BioPharmaceutical Research Triangle Park, North Carolina, USA	Metabolic	Phase 1\|Phase 2\|Preclinical	VIEW
110.	Aspen Global Incorporated Grand Bay, Mauritius	Oncology Cardiovascular Metabolic+1	Commercial	VIEW
111.	Assertio Holdings, Inc. Lake Forest, USA	Neuroscience Immunology Oncology	Commercial	VIEW
112.	Assistance Publique - Hôpitaux de Marseille (AP-HM) Marseille, France	Rare Diseases Oncology	Clinical	VIEW
113.	AtaiBeckley (formerly ATAI Life Sciences) Berlin, Germany (original); U.S. redomiciliation completed December 30, 2025		Phase 2	VIEW
114.	Atara Biotherapeutics, Inc. Thousand Oaks, California, USA	Oncology Immunology	Clinical	VIEW
115.	Atea Pharmaceuticals Boston, Massachusetts, United States		Phase 3 (HCV), Phase 1 planned (HEV)	VIEW
116.	Aucta Pharmaceuticals Basking Ridge, New Jersey, USA	Dermatology Ophthalmology Respiratory	Commercial \| Phase 2 \| Preclinical	VIEW
117.	AudioCure Pharma GmbH Berlin, Germany		Phase 2	VIEW
118.	Aurion Biotech Seattle, USA	Ophthalmology	Phase 3	VIEW
119.	AusperBio San Francisco, USA	Infectious Disease	Phase 2	VIEW
120.	Autobahn Therapeutics San Diego, USA	Neuroscience	Phase 2	VIEW
121.	Autolus Therapeutics London, United Kingdom	Oncology Immunology Rare Diseases	Commercial + Phase 1/2	VIEW
122.	Avalon Pharma (Middle East Pharmaceutical Industries Co.) Riyadh, Saudi Arabia	Dermatology Respiratory Cardiovascular+3	Commercial	VIEW
123.	Avenzo Therapeutics San Diego, USA	Oncology	Phase 2	VIEW
124.	Avid Brands S.A. (Pty) Ltd Durban, South Africa	Dermatology	Commercial	VIEW
125.	Avista Healthcare Partners New York, USA	Dermatology	-	VIEW
126.	Axalbion Lausanne, Switzerland	Respiratory Ophthalmology Neuroscience	Phase 2	VIEW
127.	Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione (ARNAS) G. Brotzu Cagliari, Italy	Oncology Hematology Metabolic	Commercial	VIEW
128.	AziraMed Strategy Waterford, Ireland		-	VIEW
129.	Azurity Pharmaceuticals Woburn, USA	Cardiovascular Metabolic Gastroenterology+2	Commercial	VIEW
130.	B.Grimm Pharma Bangkok, Thailand	Cardiovascular Gastroenterology Infectious Disease+1	Commercial	VIEW
131.	BGI Group Shenzhen, China	Oncology Rare Diseases Infectious Disease	Commercial	VIEW
132.	BIAL São Mamede do Coronado, Trofa, Porto, Portugal	Cardiovascular Rare Diseases	Phase 2 (lead candidate)	VIEW
133.	BIKEN Foundation Suita, Japan	Infectious Disease	Commercial	VIEW
134.	BIOCAD Saint Petersburg, Russia	Oncology Immunology Infectious Disease	Commercial	VIEW
135.	BIOVIIIx Naples, Italy	Rare Diseases Hematology Oncology	Discovery	VIEW
136.	BRIM Biotechnology, Inc. Taipei, Taiwan	Ophthalmology Rare Diseases	Phase 3	VIEW
137.	Bain Capital Boston, USA	Oncology Rare Diseases Neuroscience	Commercial	VIEW
138.	Basilea Pharmaceutica Allschwil, Switzerland	Infectious Disease	Phase 3	VIEW
139.	Bavarian Nordic A/S Hellerup, Denmark	Infectious Disease Oncology Immunology	Commercial	VIEW
140.	BeBetter Med Inc. Guangzhou, China	Oncology	Commercial	VIEW
141.	BeBioSol India		-	VIEW
142.	BeOne Medicines (formerly BeiGene) Cambridge, Massachusetts, United States (corporate); Basel, Switzerland (post-redomiciliation May 2025)	Oncology	Phase 1-3 and Commercial	VIEW
143.	Beacon Pharmaceuticals PLC Dhaka, Bangladesh	Oncology Cardiovascular Metabolic+2	Commercial	VIEW
144.	Beeline Medicines Boston, USA	Immunology Dermatology	Phase 2	VIEW
145.	Beijing Sungen Biomedical Technology Co., Ltd. Beijing, China	Cardiovascular Oncology Infectious Disease	Phase 2	VIEW
146.	Belenos Biosciences New York, NY, USA	Immunology Respiratory Dermatology	Phase 1/2	VIEW
147.	Belief BioMed Shanghai, China	Rare Diseases Hematology Neuroscience+1	Commercial	VIEW
148.	Belupo d.d. Koprivnica, Croatia	Cardiovascular Dermatology Infectious Disease	Commercial	VIEW
149.	BenevolentAI London, United Kingdom	Oncology Immunology Neuroscience+3	Phase 1\|Phase 2\|Preclinical	VIEW
150.	Benitec Biopharma Inc. Hayward, California, USA	Infectious Disease Oncology	Phase 1b/2a (BB-301), Preclinical (other programs)	VIEW
151.	Beren Therapeutics P.B.C. Thousand Oaks, USA	Rare Diseases	Phase 3	VIEW
152.	Berg Health Framingham, Massachusetts, USA	Oncology Neuroscience Rare Diseases	Phase 1/2	VIEW
153.	Besins Healthcare Monaco, Monaco	Metabolic	Commercial	VIEW
154.	Beta Drugs Limited Panchkula, India	Oncology Dermatology	Commercial	VIEW
155.	Bharat Biotech Hyderabad, India	Infectious Disease Oncology	Commercial	VIEW
156.	Bharat Serums and Vaccines Limited (BSV Group) Navi Mumbai, India		Commercial	VIEW
157.	Bicycle Therapeutics plc Cambridge, United Kingdom	Oncology	Phase 2	VIEW
158.	Bio Pharma Eco SL Spain		Discovery	VIEW
159.	Bio Usawa Inc. San Mateo, USA / Kigali, Rwanda	Oncology Infectious Disease Ophthalmology	Preclinical	VIEW
160.	Bio-Gene Technology Limited Shatin, Hong Kong		-	VIEW
161.	BioCardia, Inc. Sunnyvale, California, USA	Cardiovascular Respiratory	Phase 3	VIEW
162.	BioData Solutions Lawrence, Kansas, USA	Oncology Rare Diseases	-	VIEW
163.	BioInvent International AB Lund, Sweden	Oncology	Phase 2	VIEW
164.	BioLineRx Ltd. Modiin, Israel	Oncology Rare Diseases	Commercial	VIEW
165.	BioMarin Pharmaceutical Inc. San Rafael, USA	Hematology Metabolic Cardiovascular	Commercial	VIEW
166.	BioMed Valley Discoveries Kansas City, Missouri, USA	Oncology Immunology Rare Diseases+1	Clinical (Phase 1-2)	VIEW
167.	BioNTech Mainz, Germany	Oncology Immunology Infectious Disease	Phase 1-3	VIEW
168.	BioNTech SE Mainz, Germany	Oncology Infectious Disease Rare Diseases	Commercial	VIEW
169.	BioPartnersX Shanghai, China		Discovery	VIEW
170.	BioPharm Experts		-	VIEW
171.	BioPharma Network Milan, Italy		-	VIEW
172.	Biocase Brasil Itajaí, Brazil		Preclinical	VIEW
173.	Biocodex Mexico Mexico City, Mexico	Gastroenterology Neuroscience Rare Diseases	Commercial	VIEW
174.	Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Beijing, China	Oncology Immunology Metabolic+1	Phase 2	VIEW
175.	Biohaven Ltd. New Haven, USA	Neuroscience Immunology Oncology+1	Phase 3	VIEW
176.	Biological E. Limited Hyderabad, India	Infectious Disease Gastroenterology	Commercial	VIEW
177.	BiomeBank Adelaide, Australia	Infectious Disease Gastroenterology Metabolic	Clinical	VIEW
178.	Biomea Fusion San Carlos, USA	Metabolic Oncology	Phase 2	VIEW
179.	Biomed Industries, Inc. San Jose, USA	Metabolic	Phase 2/3	VIEW
180.	Biomedica Munich, Germany	Rare Diseases Oncology Hematology+2	Commercial	VIEW
181.	Bionexus (주식회사 바이오넥서스) Suwon, South Korea		Discovery	VIEW
182.	Bioreaction.tech (Bioreaction.tech Kft.) Debrecen, Hungary		Seed	VIEW
183.	BioscienceLA Culver City, USA		-	VIEW
184.	Biotest AG Dreieich (Frankfurt), Germany	Hematology	Phase 3/Commercial	VIEW
185.	Biotest AG Dreieich, Germany	Hematology	Phase 2\|Phase 3\|Commercial	VIEW
186.	Biovet AD Peshtera, Bulgaria		Commercial	VIEW
187.	Biovia Ghent, Belgium		-	VIEW
188.	Bioxodes Gosselies, Belgium	Neuroscience Immunology	Phase 2	VIEW
189.	BirchBioMed Inc. Vancouver, Canada	Dermatology Rare Diseases	Phase 2/3	VIEW
190.	Blau Farmacêutica S.A. Cotia, Brazil	Immunology Hematology Oncology+1	Commercial	VIEW
191.	BlossomHill Therapeutics San Diego, USA	Oncology Immunology	Phase 1	VIEW
192.	BlueRock Therapeutics Cambridge, USA	Neuroscience Cardiovascular Ophthalmology+1	Phase 3	VIEW
193.	Blueprint Medicines Cambridge, USA	Oncology Hematology Immunology+1	Commercial	VIEW
194.	Boostimmune Seoul, South Korea	Oncology Immunology	Preclinical	VIEW
195.	Bota Biosciences Hangzhou, China (International HQ in Lafayette, CA, USA)		Commercial	VIEW
196.	Bova (Bova UK / Bova Australia) London, United Kingdom	Dermatology	Commercial	VIEW
197.	Bracco Sine Pharmaceutical Corp. Ltd. Shanghai, China	Cardiovascular Oncology	Commercial	VIEW
198.	BrainXell, Inc. Madison, WI, USA	Neuroscience Rare Diseases	Preclinical	VIEW
199.	BridgeBio Oncology Therapeutics, Inc. South San Francisco, USA	Oncology	Phase 1	VIEW
200.	Bright Peak Therapeutics Allschwil, Switzerland	Oncology	Phase 1/2a	VIEW
201.	Brise Pharmaceuticals Shanghai, China		Phase 2	VIEW
202.	Bukwang Pharmaceutical Co., Ltd. Seoul, South Korea	Neuroscience Oncology	Phase 2	VIEW
203.	BunyaVax Lelystad, Netherlands	Infectious Disease Oncology	Phase 1	VIEW
204.	Burke Therapeutics, LLC Hot Springs, Arkansas, USA	Dermatology	Discovery	VIEW
205.	C-Ray Therapeutics Chengdu, China	Oncology	Preclinical\|Phase 1\|Phase 2\|Phase 3\|Commercial	VIEW
206.	CAMP4 Therapeutics Cambridge, USA	Rare Diseases	Phase 1	VIEW
207.	CCL Pharmaceuticals (Pvt.) Limited Lahore, Pakistan	Cardiovascular Gastroenterology Respiratory+2	Commercial	VIEW
208.	CDR-Life Schlieren, Zurich, Switzerland	Oncology Immunology Ophthalmology	Phase 1	VIEW
209.	CEA (Commissariat à l'énergie atomique et aux énergies alternatives) Paris and Gif-sur-Yvette, France	Infectious Disease Oncology	Discovery	VIEW
210.	CECOS University of Information Technology and Emerging Sciences Peshawar, Pakistan	Oncology Neuroscience Infectious Disease	Preclinical	VIEW
211.	CEPI Oslo, Norway	Infectious Disease	Commercial	VIEW
212.	CF PharmTech, Inc. Suzhou, China	Respiratory	Commercial	VIEW
213.	CG Oncology, Inc. Irvine, USA	Oncology	Phase 3	VIEW
214.	CHA University Seongnam-si, South Korea		Discovery	VIEW
215.	CHA University Seongnam, South Korea		Discovery	VIEW
216.	CHUV (Centre Hospitalier Universitaire Vaudois) Lausanne, Switzerland	Oncology Immunology Neuroscience+2	Phase 3	VIEW
217.	CRIT S.r.l. Vignola, Italy		-	VIEW
218.	CRUK Scotland Institute Glasgow, United Kingdom	Oncology	Discovery	VIEW
219.	CS Pharmaceuticals Limited London, United Kingdom	Ophthalmology Rare Diseases	Phase 2	VIEW
220.	CSM Consulting, LLC United States	Cell Therapy Gene Therapy	-	VIEW
221.	CURE5 Foundation New York, USA	Rare Diseases Neuroscience	Discovery	VIEW
222.	Cabaletta Bio, Inc. Philadelphia, USA	Immunology Neuroscience Dermatology	Phase 1/2	VIEW
223.	Cal Crop USA USA		-	VIEW
224.	Caldera Therapeutics Cambridge, USA	Immunology Gastroenterology	Phase 1	VIEW
225.	Calico Life Sciences South San Francisco, United States	Oncology Neuroscience Immunology	Phase 2	VIEW
226.	Calidi Biotherapeutics San Diego, USA	Oncology	Phase 2	VIEW
227.	Calliditas Therapeutics Stockholm, Sweden	Rare Diseases	Commercial	VIEW
228.	Calluna Pharma Oslo, Norway	Immunology	Phase 2	VIEW
229.	Camelx Riyadh, Saudi Arabia		Discovery	VIEW
230.	Camurus AB Lund, Sweden	Neuroscience Rare Diseases Metabolic+1	Commercial	VIEW
231.	CanariaBio Inc. Seoul, South Korea	Oncology	Phase 3	VIEW
232.	Cancer Research UK London, United Kingdom	Oncology	Phase 2	VIEW
233.	Cantargia AB Lund, Sweden	Oncology Immunology	Phase 1 - Phase 2	VIEW
234.	Captor Therapeutics Wroclaw, Poland	Oncology Immunology	Preclinical	VIEW
235.	Capulus Therapeutics LLC San Francisco, United States	Oncology	Preclinical	VIEW
236.	Carbyne Equity Partners Hamburg, Germany		-	VIEW
237.	Cardurion Pharmaceuticals Burlington, United States	Cardiovascular	Phase 2	VIEW
238.	Care Pharmaceuticals Bondi Junction, Australia	Respiratory Gastroenterology Ophthalmology	Commercial	VIEW
239.	Caritas Healthcare Private Limited Ahmedabad, India	Oncology	Commercial	VIEW
240.	Carol Davila University of Medicine and Pharmacy Bucharest, Romania	Oncology Cardiovascular Rare Diseases	Discovery	VIEW
241.	Carrick Therapeutics Dublin, Ireland	Oncology	Phase 2	VIEW
242.	Carroll Bio-Consulting Boston, USA	Oncology Rare Diseases	Commercial	VIEW
243.	Catalyst Pharmaceuticals, Inc. Coral Gables, USA	Rare Diseases Neuroscience	Commercial	VIEW
244.	Cell-Tx Seoul, South Korea	Neuroscience Oncology Ophthalmology	Preclinical	VIEW
245.	Cellectar Biosciences, Inc. Florham Park, USA	Oncology Hematology	Phase 2	VIEW
246.	Cellectis Paris, France	Oncology Immunology Rare Diseases	Phase 2	VIEW
247.	Celon Pharma Łomianki, Poland	Neuroscience Oncology Immunology+1	Phase 3	VIEW
248.	Celularity Inc Florham Park, New Jersey, USA	Oncology	Phase 1/2 and Phase 2	VIEW
249.	Centaur Laboratories Private Limited Mumbai, India		-	VIEW
250.	Center for Genetic Engineering and Biotechnology (CIGB) Havana, Cuba	Oncology Metabolic Infectious Disease+1	Commercial	VIEW
251.	Center for Neuromusculoskeletal Restorative Medicine Limited Shatin, Hong Kong	Neuroscience Rare Diseases	Preclinical	VIEW
252.	Center of Molecular Immunology (CIM) Havana, Cuba	Oncology Immunology	Commercial	VIEW
253.	Centessa Pharmaceuticals Altrincham, United Kingdom	Neuroscience	Phase 2	VIEW
254.	Centrexion Therapeutics Boston, Massachusetts, United States	Immunology	Phase 1-3	VIEW
255.	Cerevel Therapeutics Cambridge, Massachusetts, USA		Phase 1-3	VIEW
256.	Chan Zuckerberg Biohub Network San Francisco, USA	Infectious Disease Rare Diseases Immunology	Discovery	VIEW
257.	Changchun GeneScience Pharmaceutical Co., Ltd. Changchun, China	Metabolic Oncology Immunology+1	Clinical	VIEW
258.	Chengdu Kanghong Pharmaceutical Group Chengdu, China	Ophthalmology Neuroscience Oncology	Commercial	VIEW
259.	Chiba University Chiba, Japan	Oncology Immunology Rare Diseases+3	Phase 2	VIEW
260.	China Isotope & Radiation Corporation (CIRC) Beijing, China	Oncology Cardiovascular	Commercial	VIEW
261.	China Medical System Holdings Ltd. Shenzhen, China	Dermatology Gastroenterology Ophthalmology+1	Commercial	VIEW
262.	China Medical University Hospital (CMUH) Taichung, Taiwan	Oncology Neuroscience Cardiovascular+2	Phase 2	VIEW
263.	Chongqing PegBio Biotechnology Co., Ltd. Chongqing, China	Gastroenterology Hematology Oncology	Phase 3	VIEW
264.	Choose Life Biotech SA Bellinzona, Switzerland	Immunology Infectious Disease Oncology	Preclinical	VIEW
265.	Chosun University Hospital Gwangju, South Korea	Oncology Metabolic Gastroenterology	Discovery	VIEW
266.	ChuanXin Biomedicine Suzhou, China	Infectious Disease Oncology	Phase 1	VIEW
267.	Chung-Ang University Seoul, South Korea	Oncology Cardiovascular Immunology+2	Phase 3	VIEW
268.	Cincinnati Children's Hospital Medical Center Cincinnati, USA	Oncology Immunology Rare Diseases+4	Commercial	VIEW
269.	Circio Holding ASA Lysaker, Norway	Oncology Immunology Gene Therapy	Phase 1/2	VIEW
270.	City of Hope Duarte, California, USA	Oncology Hematology Rare Diseases	Commercial	VIEW
271.	Clasp Therapeutics Rockville, Maryland, USA	Oncology	Phase 1	VIEW
272.	ClearB Therapeutics, Inc. Concord, Massachusetts, USA	Infectious Disease	Phase 1	VIEW
273.	Cleveland Clinic Foundation Cleveland, Ohio, USA	Oncology Cardiovascular Neuroscience+2	Discovery	VIEW
274.	Clever Culture Systems Adelaide, Australia		Commercial	VIEW
275.	Clinny Bio		-	VIEW
276.	Clinuvel Pharmaceuticals Melbourne, Australia	Rare Diseases Dermatology Neuroscience	Commercial	VIEW
277.	Coave Therapeutics Paris, France	Ophthalmology Neuroscience Rare Diseases	Preclinical	VIEW
278.	Cobel Darou Tehran, Iran	Cardiovascular Oncology Metabolic+3	Commercial	VIEW
279.	Cochener Garvey Capital Partners Wichita, USA		-	VIEW
280.	Codexis, Inc. Redwood City, California, USA	Rare Diseases Metabolic	Commercial	VIEW
281.	Coherus BioSciences, Inc. Redwood City, USA	Oncology	Commercial	VIEW
282.	College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences (SRIPMS) Coimbatore, India		-	VIEW
283.	Comanche Biopharma Corp. Concord, USA		Phase 1	VIEW
284.	Complement Therapeutics United Kingdom (University of Manchester spinout, with facilities in UK and Germany)	Ophthalmology	Phase I/II	VIEW
285.	Consonance Capital New York, USA	Oncology Rare Diseases	Discovery	VIEW
286.	Constructor Group Schaffhausen, Switzerland	Oncology Infectious Disease Neuroscience	Preclinical	VIEW
287.	Cook MyoSite, Inc. Pittsburgh, USA	Gastroenterology	Phase 3	VIEW
288.	Corbus Pharmaceuticals Holdings, Inc. Norwood, Massachusetts, USA	Oncology Metabolic	Phase 3	VIEW
289.	Corcept Therapeutics Redwood City, USA	Metabolic Oncology Neuroscience	Commercial	VIEW
290.	Corline Biomedical AB Uppsala, Sweden	Metabolic Cardiovascular Neuroscience	Phase 2	VIEW
291.	Corona Remedies Limited Ahmedabad, India	Cardiovascular Gastroenterology Respiratory	Commercial	VIEW
292.	CortiSci	Neuroscience	Discovery	VIEW
293.	Cosmica Biosciences San Francisco, USA		Discovery	VIEW
294.	Cosmo Pharmaceuticals N.V. Dublin, Ireland	Gastroenterology Dermatology Infectious Disease	Commercial	VIEW
295.	Coya Therapeutics, Inc. Houston, USA	Immunology	Phase 2	VIEW
296.	Createrna Science and Technology Wuhan, China	Cardiovascular Respiratory Immunology	Phase 2	VIEW
297.	Crescent Biopharma, Inc. Waltham, USA	Oncology	Phase 1/2	VIEW
298.	Crescent Pharma Basingstoke, United Kingdom	Oncology Cardiovascular Infectious Disease	Commercial	VIEW
299.	Crixmor LLC Malvern, Pennsylvania, USA	Immunology Gastroenterology Oncology	Discovery	VIEW
300.	CryoLife Scientific LLP Thane, India		Discovery	VIEW
301.	Cugene Inc. Waltham, USA	Oncology Immunology	Phase 1	VIEW
302.	Cullinan Therapeutics Cambridge, USA	Oncology Immunology	Phase 3	VIEW
303.	CuraTeQ Biologics Hyderabad, India	Oncology Immunology Metabolic	Commercial	VIEW
304.	CuraVac Rixensart, Belgium	Immunology	Phase 1B (completed) \| Phase 2 (in preparation)	VIEW
305.	Curadev Pharma Pvt Ltd Noida, India	Oncology Immunology Metabolic	Phase 1	VIEW
306.	Curaleaf Holdings, Inc. Wakefield, Massachusetts, USA		Commercial	VIEW
307.	Curasight Copenhagen, Denmark	Oncology	Phase 1-2 Clinical	VIEW
308.	Curatis Liestal, Switzerland	Oncology Neuroscience Respiratory+1	Phase 3	VIEW
309.	Curative Biotechnology Inc Boca Raton, Florida, USA	Infectious Disease	Pre-Clinical\|IND-Enabling Studies	VIEW
310.	CureVac Tübingen, Germany	Oncology Infectious Disease Rare Diseases	Phase 2	VIEW
311.	Curis, Inc. Lexington, USA	Oncology	Phase 1/2	VIEW
312.	Curium Pharma Boston, USA	Oncology	Commercial	VIEW
313.	Curocell Inc. Daejeon, South Korea	Oncology Hematology	Commercial	VIEW
314.	CytoAgents Pittsburgh, USA	Oncology Immunology Infectious Disease+1	Phase 2	VIEW
315.	CytoDyn Inc Vancouver, Washington	Oncology Immunology	Phase 2 clinical	VIEW
316.	CytoImmune Therapeutics Duarte, USA	Oncology Hematology Immunology	Phase 1	VIEW
317.	CytoSen Therapeutics Orlando (Winter Springs), Florida, USA	Oncology Cell Therapy Immunology	Phase 2	VIEW
318.	CytoTools AG Heidelberg, Germany	Dermatology Cardiovascular Oncology	Phase 3	VIEW
319.	CytoVac Hørsholm, Denmark	Oncology	Phase 2	VIEW
320.	Cytochroma Edinburgh, United Kingdom	Cardiovascular Rare Diseases	Discovery	VIEW
321.	Cytocom, Inc. Fort Collins, Colorado, USA	Oncology Infectious Disease Hematology+1	Phase 2/Phase 3	VIEW
322.	Cytokinetics, Incorporated South San Francisco, USA	Cardiovascular	Commercial	VIEW
323.	Cytolab SPA Boumerdès, Algeria		Commercial	VIEW
324.	CytomX Therapeutics, Inc. South San Francisco, California, United States	Oncology	Phase 1 (clinical), Preclinical (discovery collaborations)	VIEW
325.	Cytomos Edinburgh, United Kingdom	Cell Therapy Gene Therapy Oncology	Commercial	VIEW
326.	Cytonics Corporation Jupiter, Florida, USA	Immunology	Phase 2	VIEW
327.	Cytonus Therapeutics Carlsbad, California, United States	Oncology Immunology Infectious Disease+1	Phase 1	VIEW
328.	Cytorex Biosciences Weston, Florida, USA	Oncology Metabolic Infectious Disease	Preclinical	VIEW
329.	Cytovation Bergen, Norway	Oncology Rare Diseases	Phase I/II - Phase II	VIEW
330.	Cytovia Therapeutics Aventura, Florida, USA	Oncology Immunology	Phase 1/2	VIEW
331.	Cyxone Malmö, Sweden	Immunology Neuroscience	Phase 2	VIEW
332.	D&D Pharmatech Seongnam-si, South Korea		Phase 2	VIEW
333.	DBV Technologies Châtillon, France	Immunology	Phase 3	VIEW
334.	Daeyeon Chemical Co., Ltd. Seongnam-si, South Korea		-	VIEW
335.	Dankook University Yongin and Cheonan, South Korea	Oncology Neuroscience Rare Diseases+1	Phase 2	VIEW
336.	Dartmouth College Hanover, USA	Oncology Immunology Neuroscience+2	Phase 3	VIEW
337.	Day One Biopharmaceuticals Brisbane, United States	Oncology Rare Diseases	Commercial	VIEW
338.	Debiopharm Lausanne, Switzerland	Oncology Rare Diseases	Phase 1, Phase 2, Phase 3	VIEW
339.	Deep Life Medical Ltd Edinburgh, United Kingdom		Phase 1	VIEW
340.	Denali Therapeutics Inc. South San Francisco, USA		Commercial	VIEW
341.	Dendreon Pharmaceuticals Seal Beach, USA	Oncology	Commercial	VIEW
342.	DesiCorp Inc. Louisville, USA		Preclinical	VIEW
343.	DevaCell, Inc. San Diego, USA	Oncology Infectious Disease Gene Therapy	Preclinical	VIEW
344.	Development Center for Biotechnology (DCB) Taipei, Taiwan	Oncology Immunology Infectious Disease	Preclinical	VIEW
345.	Dexa Medica Tangerang, Indonesia	Oncology	Commercial	VIEW
346.	Dexcel Pharma Or Akiva, Israel	Oncology Cardiovascular Neuroscience+2	Commercial	VIEW
347.	Diamond Pharma Damascus, Syria	Cardiovascular Respiratory	Commercial	VIEW
348.	DifGen Pharmaceuticals Miramar, USA	Ophthalmology Neuroscience	Commercial	VIEW
349.	Differential Bio Munich, Germany		Commercial	VIEW
350.	Dignify Therapeutics Research Triangle Park, NC, USA	Neuroscience Gastroenterology	Clinical	VIEW
351.	Disc Medicine, Inc. Watertown, Massachusetts, USA	Hematology Rare Diseases	Phase 3	VIEW
352.	Dizal Pharmaceutical Shanghai, China	Oncology Immunology	Commercial	VIEW
353.	Dolomite TX		-	VIEW
354.	Dolor Therapeutics, Inc. Chicago, USA	Immunology	Preclinical	VIEW
355.	Dompé Farmaceutici Milan, Italy	Ophthalmology Rare Diseases Metabolic+2	Commercial	VIEW
356.	Dr. Falk Pharma GmbH Freiburg, Germany	Gastroenterology Immunology	Phase 3	VIEW
357.	Dr. L. H. Hiranandani College of Pharmacy Ulhasnagar, India		Discovery	VIEW
358.	Drugs for Neglected Diseases initiative (DNDi) Geneva, Switzerland	Infectious Disease	Commercial	VIEW
359.	Duality Biologics Shanghai, China	Oncology Immunology	Phase 3	VIEW
360.	Duopharma Biotech Berhad Kuala Lumpur, Malaysia	Oncology Cardiovascular Metabolic+1	Commercial	VIEW
361.	Dyne Therapeutics, Inc. Waltham, Massachusetts, USA		Phase 1/2, Phase 3	VIEW
362.	E-Flask Seongnam, South Korea	Neuroscience Oncology	Phase 1	VIEW
363.	EEE Pharma Maharashtra, India	Infectious Disease Immunology Cardiovascular+1	Commercial	VIEW
364.	EIPICO 10th of Ramadan City, Egypt	Oncology Ophthalmology Cardiovascular+1	Phase 3	VIEW
365.	EIPICO 10th of Ramadan City, Egypt	Oncology Ophthalmology Cardiovascular+1	Phase 3	VIEW
366.	ETH Zürich Zurich, Switzerland	Oncology Immunology Neuroscience+4	Discovery	VIEW
367.	EUBREAST Esslingen, Germany	Oncology	Phase 3	VIEW
368.	East West Pharma Salem, India	Cardiovascular Dermatology	Commercial	VIEW
369.	Edge Therapeutics, Inc. Princeton, New Jersey, USA	Oncology Infectious Disease	Phase 3	VIEW
370.	Edgewise Therapeutics Boulder, USA		Phase 2	VIEW
371.	EdiLabs OÜ Harku, Estonia	Neuroscience Immunology	Discovery	VIEW
372.	Efroze Chemical Industries (Pvt.) Ltd. Karachi, Pakistan	Cardiovascular Gastroenterology	Commercial	VIEW
373.	Eledon Pharmaceuticals Irvine, USA	Immunology	Phase 2	VIEW
374.	Elevar Therapeutics Fort Lee, USA	Oncology	Phase 3	VIEW
375.	Eleven Therapeutics Cambridge, United Kingdom	Infectious Disease	Discovery	VIEW
376.	Elixiron Immunotherapeutics Taipei, Taiwan	Oncology Immunology	Phase 2	VIEW
377.	Ellipses Pharma London, United Kingdom	Oncology	Phase 1/2	VIEW
378.	Emergent BioSolutions Gaithersburg, Maryland, USA	Infectious Disease	Commercial	VIEW
379.	Empiri Inc. Houston, USA	Oncology	Commercial	VIEW
380.	Empresa de Laboratorios AICA La Lisa, Havana, Cuba	Infectious Disease Oncology	Commercial	VIEW
381.	Enanta Pharmaceuticals, Inc. Watertown, Massachusetts, USA	Immunology	Phase 1-2 clinical	VIEW
382.	Eneapharm Labège, France	Gastroenterology Rare Diseases	Clinical	VIEW
383.	Enigma Biomedical Group Toronto, Canada		Commercial	VIEW
384.	Enlivex Therapeutics Ltd. Ness Ziona, Israel	Immunology Oncology Infectious Disease	Phase 2	VIEW
385.	Ensem Therapeutics Waltham, MA, USA	Oncology	Phase 1/2	VIEW
386.	Entact Bio Watertown, USA	Oncology Immunology Rare Diseases	Preclinical	VIEW
387.	Enveda Biosciences Boulder, USA	Immunology Metabolic Dermatology	Clinical	VIEW
388.	Enzo Biochem, Inc. Farmingdale, New York, USA	Oncology Infectious Disease	Discovery	VIEW
389.	Epione Medicine ApS Hvidovre, Denmark		-	VIEW
390.	Erasmus MC Rotterdam, Netherlands	Oncology Rare Diseases	Discovery	VIEW
391.	Eris Therapeutics Limited Ahmedabad, India	Cardiovascular Gastroenterology Dermatology	Commercial	VIEW
392.	Estetra SRL Liège, Belgium	Oncology	Commercial	VIEW
393.	Ethypharm Saint-Cloud, France	Neuroscience	Commercial	VIEW
394.	Eugia US LLC East Windsor, New Jersey, USA	Oncology Respiratory Hematology+2	Commercial	VIEW
395.	EurimPharm Arzneimittel GmbH Saaldorf-Surheim, Germany	Oncology Immunology Neuroscience+2	Commercial	VIEW
396.	Everest Medicines Shanghai, China	Immunology Oncology Cardiovascular+1	Commercial	VIEW
397.	Evopoint Biosciences Suzhou, China	Oncology Infectious Disease Immunology	Commercial (NDA Stage)	VIEW
398.	Evotec SE Hamburg, Germany	Oncology Neuroscience Infectious Disease+1	Commercial	VIEW
399.	Evox Therapeutics Oxford, United Kingdom	Rare Diseases Oncology	Preclinical	VIEW
400.	Exelixis Alameda, USA	Oncology	Commercial	VIEW
401.	Exeltis Florham Park, USA (Global HQ in Madrid, Spain)	Neuroscience Respiratory Dermatology+2	Commercial	VIEW
402.	Exir Pharmaceutical Company Tehran, Iran		Commercial	VIEW
403.	Exlixis		-	VIEW
404.	EyePoint Pharmaceuticals Watertown, Massachusetts, USA	Ophthalmology	Phase 3	VIEW
405.	FDC Limited Mumbai, India	Gastroenterology Ophthalmology Cardiovascular+2	Commercial	VIEW
406.	FELIQS Corporation Fukuoka, Japan	Ophthalmology Rare Diseases	Phase 1	VIEW
407.	FNCT Biotech Seongnam-si, South Korea	Oncology Immunology	Preclinical	VIEW
408.	FORE Biotherapeutics Philadelphia, USA	Oncology	Phase 2	VIEW
409.	Faculty of Pharmacy, Cairo University Cairo, Egypt		Discovery	VIEW
410.	Faes Farma Leioa, Spain	Gastroenterology Ophthalmology Dermatology	Phase 3	VIEW
411.	Fapon Dongguan, China	Oncology Immunology Infectious Disease	Preclinical	VIEW
412.	Farma de Colombia S.A.S. Bogotá, Colombia	Gastroenterology Cardiovascular Oncology	Commercial	VIEW
413.	Farmacéutica Hispanoamericana S.A. de C.V. Ciudad de México, Mexico	Respiratory Cardiovascular Gastroenterology	Commercial	VIEW
414.	Farmak Kyiv, Ukraine	Metabolic Gastroenterology Cardiovascular+3	Commercial	VIEW
415.	Farmaprim Porumbeni, Moldova		Commercial	VIEW
416.	Farne Bio		-	VIEW
417.	Faron Pharmaceuticals Turku, Finland	Oncology Hematology	Phase 2	VIEW
418.	Fate Therapeutics, Inc. San Diego, USA	Oncology	Phase 1	VIEW
419.	Feldan Therapeutics Québec City, Canada	Oncology Dermatology	Preclinical	VIEW
420.	FenoMark Diagnostics AB Solna, Sweden	Oncology	Discovery	VIEW
421.	Filos Biopharma LLP Hyderabad, India		Discovery	VIEW
422.	Fiocruz (Oswaldo Cruz Foundation) Rio de Janeiro, Brazil	Infectious Disease	Commercial	VIEW
423.	Fiocruz (Oswaldo Cruz Foundation) Rio de Janeiro, Brazil	Infectious Disease Vaccines Rare Diseases+1	Commercial	VIEW
424.	Fishfa Biogenics Rajkot, India	Immunology Infectious Disease Oncology+1	Commercial	VIEW
425.	Flagship Pioneering Cambridge, USA	Oncology Immunology Cardiovascular+2	Discovery	VIEW
426.	Flare Therapeutics Cambridge, MA, USA	Oncology	Phase 1-1B	VIEW
427.	FluGen, Inc. Madison, USA	Infectious Disease	Phase 2	VIEW
428.	Focus Care Pharmaceuticals B.V. Zaandam, Netherlands	Respiratory Neuroscience Cardiovascular+1	Commercial	VIEW
429.	For Benefit Medicines Sydney, Australia	Oncology	Commercial	VIEW
430.	Forma Therapeutics Inc Watertown, USA	Hematology Oncology Rare Diseases	Phase 3	VIEW
431.	Formation Bio New York, USA	Immunology Dermatology Neuroscience	Phase 3	VIEW
432.	Formycon AG Planegg-Martinsried, Germany	Ophthalmology Immunology	Commercial	VIEW
433.	Frontier Medicines South San Francisco, USA	Oncology Immunology	Phase 1/2	VIEW
434.	Fundação Butantan São Paulo, Brazil	Infectious Disease	Phase 2	VIEW
435.	Fusion Pharmaceuticals Inc. Hamilton, Ontario, Canada	Oncology	Phase 1\|Phase 2\|Phase 3	VIEW
436.	Future Health Biobank Nottingham, United Kingdom		-	VIEW
437.	G. H. Raisoni University Saikheda, India	Oncology Metabolic Neuroscience+1	Discovery	VIEW
438.	GEN İlaç Ankara, Turkey	Oncology Neuroscience Metabolic+3	Phase 1\|Phase 2\|Commercial	VIEW
439.	GENFIT Loos, France	Metabolic	Phase 2	VIEW
440.	GNT Pharma Yongin, South Korea	Neuroscience Respiratory	Phase 3	VIEW
441.	Galapagos NV Mechelen, Belgium	Immunology Oncology	Phase 2	VIEW
442.	Galen Limited Craigavon, United Kingdom	Dermatology Gastroenterology Metabolic	Commercial	VIEW
443.	Galenicap BV Brussels, Belgium	Oncology Neuroscience Infectious Disease	Phase 2	VIEW
444.	Galpha Laboratories Limited Mumbai, India	Infectious Disease Gastroenterology Dermatology	Commercial	VIEW
445.	Gan & Lee Pharmaceuticals Beijing, China	Metabolic Oncology Cardiovascular	Commercial	VIEW
446.	GenAns Biotech Beijing, China	Neuroscience Ophthalmology Oncology	Preclinical	VIEW
447.	GenLumina Leiden, Netherlands	Oncology	Preclinical	VIEW
448.	Gene Oasis Singapore, Singapore	Oncology Neuroscience Immunology+1	Clinical	VIEW
449.	GeneBiology, Inc. Research Triangle Park, North Carolina, USA	Oncology Neuroscience Gastroenterology	Clinical	VIEW
450.	GeneScience Pharmaceuticals Co., Ltd. (GenSci) Changchun, China	Metabolic Immunology Respiratory+1	Commercial	VIEW
451.	GeneTex, Inc. Irvine, USA	Oncology Immunology Neuroscience+1	-	VIEW
452.	Genelytica Sp. z o.o. Łomża, Poland	Oncology	Discovery	VIEW
453.	Genentech South San Francisco, California, United States	Oncology Immunology Rare Diseases+3	Discovery through Commercial	VIEW
454.	Generare Paris, France	Oncology Immunology	Discovery	VIEW
455.	Genfarma Joint Stock Company Hanoi, Vietnam	Oncology Immunology Neuroscience+1	Commercial	VIEW
456.	Genfoquest Analytica Izmir, Türkiye	Oncology Immunology	Discovery	VIEW
457.	Genmab Copenhagen, Denmark	Oncology Hematology Immunology	Commercial	VIEW
458.	Gensciences Nantong, China	Hematology	Phase 3	VIEW
459.	George Mason University Fairfax, USA	Oncology Infectious Disease Metabolic+2	Phase 2	VIEW
460.	Georgia Southern University Statesboro, USA	Oncology Infectious Disease Neuroscience+1	Discovery	VIEW
461.	Gesynta Pharma AB Stockholm, Sweden		Phase 2	VIEW
462.	Ghosts Past		-	VIEW
463.	Google (Google DeepMind / Isomorphic Labs) London, United Kingdom	Oncology Immunology Cardiovascular	Preclinical	VIEW
464.	Granite Bio Basel, Switzerland	Immunology	Phase 1	VIEW
465.	Grit Biotechnology Shenzhen, China	Oncology Immunology	Phase 2	VIEW
466.	Grupo Leti Guarenas, Venezuela	Cardiovascular Metabolic Gastroenterology+2	Commercial	VIEW
467.	Grupo Medifarma, S.A. de C.V. Jiutepec, Mexico	Gastroenterology	Commercial	VIEW
468.	Guangzhou Cellprotek Pharmaceutical Guangzhou, China	Neuroscience Cardiovascular Immunology+1	Phase 3 (Planning)	VIEW
469.	Gustave Roussy Villejuif, France	Oncology	Discovery	VIEW
470.	HBM Partners Zug, Switzerland	Oncology Immunology Neuroscience+3	Commercial	VIEW
471.	HCW Biologics Inc. Miramar, Florida, USA	Oncology Immunology	Phase 2	VIEW
472.	HERMES Arzneimittel Holding Pullach im Isartal, Germany		Commercial	VIEW
473.	HERVolution Therapeutics Copenhagen, Denmark	Oncology	Preclinical	VIEW
474.	HGFH (Placeholder Entity) N/A		Discovery	VIEW
475.	HIPRA Amer, Spain		Commercial	VIEW
476.	HLB PEP Co., Ltd. Gwangju, South Korea	Oncology Rare Diseases Immunology	Preclinical	VIEW
477.	HUN-REN Veterinary Medical Research Institute (VMRI) Budapest, Hungary	Infectious Disease	Discovery	VIEW
478.	HUTCHMED Hong Kong	Oncology Immunology Dermatology	Discovery to Phase III	VIEW
479.	Haisco Pharmaceutical Group Co., Ltd. Shannan, China	Oncology Neuroscience Cardiovascular+1	Phase 3	VIEW
480.	Halo Life Science Austin, Texas, United States	Immunology	Discovery	VIEW
481.	Halozyme Therapeutics San Diego, USA	Oncology Immunology Neuroscience+3	Commercial	VIEW
482.	Hamad Bin Khalifa University (HBKU) Doha, Qatar	Oncology Metabolic Infectious Disease+1	Preclinical	VIEW
483.	Hanan Medicare Sdn. Bhd. Rawang, Malaysia	Metabolic	Commercial	VIEW
484.	Hanmi Pharmaceutical Co., Ltd. Seoul, South Korea	Oncology Metabolic Rare Diseases+1	Commercial	VIEW
485.	HansBiomed Seoul, South Korea	Dermatology	Commercial	VIEW
486.	Hansa Biopharma Lund, Sweden	Immunology Gene Therapy Oncology	Commercial	VIEW
487.	Hansoh Pharmaceutical Group Co., Ltd. Shanghai, China	Oncology Neuroscience Metabolic+1	Phase 3	VIEW
488.	Hanyang University Seoul, South Korea	Oncology Neuroscience Infectious Disease+1	Phase 2	VIEW
489.	Harbour BioMed Shanghai, China	Oncology Immunology Ophthalmology	Phase 3	VIEW
490.	Harmony Biosciences Holdings, Inc. Plymouth Meeting, USA	Neuroscience Rare Diseases	Commercial	VIEW
491.	Healios K.K. Tokyo, Japan	Neuroscience Oncology Ophthalmology	Phase 3	VIEW
492.	Healis Therapeutics Cambridge, USA	Neuroscience	Phase 2/3	VIEW
493.	Health Hope Pharma Hong Kong, Hong Kong	Oncology	Phase 3	VIEW
494.	Hedera Dx Epalinges, Switzerland	Oncology	Commercial	VIEW
495.	Heligenics Phoenix, Arizona, USA	Oncology Rare Diseases	Discovery	VIEW
496.	Hemerion Therapeutics Villeneuve d'Ascq, France	Oncology	Phase 1/2	VIEW
497.	HepaRegeniX GmbH Tübingen, Germany	Oncology Neuroscience	Phase 2	VIEW
498.	Heranova Lifesciences Burlington, MA, USA		Clinical	VIEW
499.	Hetero Drugs Limited Hyderabad, India	Oncology Cardiovascular Metabolic+1	Commercial	VIEW
500.	Hevolution Foundation Riyadh, Saudi Arabia	Oncology Neuroscience Rare Diseases	Discovery	VIEW